Citations

Mayo Clinic

Clear

2361 citation(s) found for "JACK, N".

Virtual reality for cardiology case-based learning
Riener, Kurtis, Subramaniam, Anna, Bird, Jared, Tan, Nicholas, Simard, Trevor, Riener, Kurtis W. , Miller, Jack R. , Al‐Abcha, Abdullah , Simard, Trevor

Frontiers in Virtual Reality | June 12, 2026 | Volume: 7 | Issue: No issue available | Pages: No page available

10.3389/frvir.2026.1841021 Get It

The ever-changing landscape of cardiology necessitates continuous education of healthcare providers. Case-based learning (CBL) provides an inquiry-based form of learning where learners apply knowledge to realistic clinical scenarios under instructor guidance. However, current case-based learning curricula are limited to representing 3-dimensional content in 2-dimensions with distinct modalities utilized for various data sources. Virtual reality (VR) shows promise for CBL given it provides an immersive and interactive 3-dimensional medium in which multi-source content can be incorporated into a unified learning experience, potentially translating to improved learning efficiency and lower cognitive load. With VR case-based learning, learners can view medical imaging in 3-dimensions or seamlessly interact with various 2-dimensional images within one unified medium. Further, additional content including simulated patients or procedures can be incorporated with a higher level of fidelity. Herein, we summarize the current literature exploring VR-CBL, demonstrate a proof-of-concept VR application, and review the implications for cardiology education. The proof-of-concept exemplifies many of the key advantages unique to VR-CBL, such as medical imaging rendered in 3-dimensions, integration of multiple imaging sources, and novel interaction methodologies. Given the importance and rapid evolution of ongoing medical education, VR-CBL, with its immersive and engaging nature, appears to be a promising form of instruction that may serve a larger role in continuing medical education initiatives.
Remote, self‐administered, smartphone cognitive testing in a registry‐based cohort: Feasibility, reliability, and validity findings
Dhanam, Sreya , Taylor, Jack C. , Fregly, Ray, Kwang, Winnie, Wise, Amy B. , Heuer, Hilary W. , Forsberg, Leah K. , Kramer, Joel H. , Rosen, Howard J., Mackin, R. Scott , Weiner, Michael W., Nosheny, Rachel L. , Boxer, Adam L., Staffaroni, Adam M. , Registry, and the Brain Health, Staffaroni, Adam M , Sanderson‐Cimino, Mark , Paolillo, Emily W. , Maruff, Paul , Boeve, Bradley F. , Boxer, Adam L. , Registry, and the Brain Health

Alzheimer's & Dementia | June 11, 2026 | Volume: 22 | Issue: 6 | Pages: No page available

10.1002/alz.71580 | PMID 42273832 Get It

Abstract BACKGROUND Remote, smartphone‐based cognitive testing may improve access to cognitive assessments for Alzheimer's disease and related dementias. We evaluated the feasibility, reliability, and validity of unsupervised smartphone‐based cognitive tests in a registry‐based cohort. METHODS Adults without a record of cognitive impairment ( N = 1815; ages 18–92) were recruited from the University of California, San Francisco (UCSF) Brain Health Registry to complete three unsupervised smartphone cognitive testing sessions within 2 weeks. Reliability was assessed with correlations between sessions. Linear regression models tested associations of smartphone tasks with demographics, self‐ and informant‐rated cognitive concerns, and web‐based cognitive testing (Cogstate Brief Battery). RESULTS Adherence was high (82.2%) and usability favorable. Test–retest reliability was moderate to strong ( ρ ’s = 0.61–0.85, all p ’s < 0.001). Lower smartphone scores were associated with older age, lower education, cognitive concerns, and worse Cogstate performance. DISCUSSION Findings support the feasibility, reliability, and validity of remote digital assessments in adults without a record of cognitive impairment.
Frequency of White Matter Hyperintensities Across Neurodegenerative Syndromes Compared to Cognitively Unimpaired Individuals (P7-12.013)
Bermudez, Camilo , Fought, Angela, Hofrenning, Ekaterina, Kantarci, Kejal, Jack, Clifford, Boeve, Bradley, Knopman, David, Ramanan, Vijay, McCarter, SJ, Petersen, Ronald, Vemuri, Prashanthi, Graff-Radford, Jonathan, Hofrenning, Ekaterina I. , Kantarci, Kejal , Jack, Clifford, Boeve, Bradley, Jones, David, Knopman, David S. , Botha, Hugo , Ramanan, Vijay K. , Petersen, Ronald, Vemuri, Prashanthi , Graff‐Radford, Jonathan

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215057 Get It

Optimizing Plasma p-tau217 Thresholds for Detection of Preclinical Alzheimer’s Disease Across Different Racial and Ethnic Backgrounds (P10-13.011)
Piura, Yoav, Lachner, Christian, Algeciras-Schimnich, Alicia, Figdore, Daniel, Petersen, Ronald, Jack, Clifford, Aduen, Paula, Schecter, Leah, Graff-Radford, Neill, Day, Gregory, Piura, Yoav , Lachner, Christian , Algeciras‐Schimnich, Alicia , Figdore, Daniel J. , Bornhorst, Joshua , Petersen, Ronald, Jack, Clifford, Aduen, Paula, Graff‐Radford, Neill R.

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215003 Get It

EGFR INHIBITION PROMOTES ENTEROENDOCRINE CELL DIFFERENTIATION CONTRIBUTING TO TREATMENT-ASSOCIATED DIARRHEA
Ramos, Guilherme Piovezani , Zeve, Daniel , Shepherd, Amy , Saint-Denis, Elisa, Aldefer, Olivia, Frintu, Bia, Dale, Stanley, Sharma, Karina, Mohlmann, Emma , Mannam, Prabhath , Byers, Morgan , Terzian, Jack, Ribeiro, Claudio D , Borges, Kleiton S., Carlone, Diana , Rao, M Prasada, Zeve, Daniel , Ribeiro, Claudio , Oliveira, Luiz Fernando , Borges, Kleiton Silva , O'Connell, Amy E , Carlone, Diana L , Duma, Narjust , Rao, Meenakshi , Breault, David T , Ramos, Guilherme P , Shepherd, Amy , Saint‐Denis, Elisa, Frintu, Bianca, Sharma, Karina, O’Connell, Amy E. , Florez, Narjust

No container title available | June 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.02.729650 | PMID 42282735 Get It

ABSTRACT Enteroendocrine cells (EECs) are specialized sensors of the gastrointestinal (GI) epithelium that regulate gut function and systemic metabolism through hormone secretion. The molecular pathways directing intestinal stem cell (ISC) differentiation into EECs are incompletely understood due, in part, to their rarity. We sought to identify novel regulators of human EEC differentiation using a high-throughput screen of FDA-approved drugs and human duodenal organoids. Two epidermal growth factor receptor inhibitors (EGFRi) commonly used in cancer therapy and known to cause GI side effects, erlotinib and lapatinib, emerged as strong inducers of EEC differentiation, dramatically increasing chromogranin A (CHGA) expression compared to controls, while maintaining ISC function and organoid growth. EGFRi-treated organoids revealed robust and broad upregulation of EEC hormones, including serotonin (5HT), motilin (MLN), and somatostatin (SST), among others. In agreement with these findings, analysis of a patient cohort with lung cancer revealed an association with erlotinib use and increased circulating levels of the above EEC hormones compared to matched controls. Supporting a direct effect of EGFRi on EEC differentiation, mice treated with erlotinib demonstrated increased EEC numbers and hormones and showed EGFRi-associated diarrhea (EAD), a limiting side effect of these medications. Mechanistically, EGFRi induced upregulation of interferon (IFN) signaling targets during early ISC-to-EEC differentiation. Consistent with this, inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) attenuated EGFRi-induced EEC differentiation. These findings provide important insight into EEC differentiation that could inform treatment strategies for EAD, metabolic diseases, and GI diseases. Brief Summary Inhibition of EGFR signaling promotes human ISC-to-EEC differentiation through activation of STAT1 signaling.
A Retrospective Evaluation of the Microsoft Healthcare Agent Orchestrator for Tumor Board Patient Summaries
Roy, Joy , Korleski, Jack , Augustin, Ryan Christian, Yefet, Leeor, Jensen, Zach D , Ehman, Eric C. , Zadeh, G Z, Conners, Amy Lynn , Tevaarwerk, Amye J, Korfiatis, Panagiotis, Yefet, Leeor S. , Tevaarwerk, Amyé , Korfiatis, Panagiotis

No container title available | June 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.22.26353812 Get It

Abstract Background Preparing tumor board patient summaries is time intensive. Large-language-model based systems may automate summarization but require real-world evaluation prior to clinical use. We performed an exploratory retrospective evaluation of the Microsoft Healthcare Agent Orchestrator (HAO), deployed in a Mayo Clinic–controlled staged environment, to generate tumor board–style patient summaries from retrospective Electronic Health Record (EHR) notes. Methods HAO generated summaries for breast, hepatobiliary, and neuro-oncology tumor board cases using up to the most recent 1,000 clinical notes. Clinician reviewers evaluated outputs via REDCap surveys across perceived factuality, completeness, clarity/conciseness, temporal cohesion, comparative performance, safety, and clinical utility (0–4 Likert scale). Reviewers were permitted to query the HAO chat interface to address missing details. Automated factuality was assessed using TBFact (bidirectional entailment), reporting precision and recall against available reference summaries. Results Among 57 survey responses from 5 different physicians, mean scores exceeded 2.8 across domains, with medians of 3 for most axes. In an exploratory comparison, oncology fellows required less time to review HAO-generated summaries than to manually generate patient summaries (mean difference 13.57 minutes per patient, p<0.001), although this difference may be influenced by prior familiarity with the same cases; 96% of survey responses indicated that HAO would save time. TBFact evaluations showed higher recall than precision across domains, consistent with broad capture of reference content alongside additional content that was not present in gold-standard summaries. Attribution was viewed favorably but showed issues with primary-source specificity and link reliability. Conclusions In a controlled Mayo environment, HAO demonstrated moderate performance and was associated with reduced review time for tumor board preparation. These findings are promising but preliminary and do not establish clinical safety, noninferiority to manual review, or readiness for routine clinical use. Limitations, including verbosity, specialty-specific content gaps, and inconsistent attribution, highlight the need for iterative refinement and further evaluation. Graphical Abstract Created using ChatGPT
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio
Algeciras-Schimnich, Alicia, Reyes, Ramiro Eduardo Rea , Ashrafzadeh-Kian, Susan, Wilson, Rachel, MD, Miller, Johnson, D H, Botha, Hugo, Day, Gregory S., Graff-Radford, Jonathan, Ramanan, Vijay K., Jack, Clifford R., Johnson, Sterling C., Zetterberg, Henrik, Petersen, Ronald C., Bornhorst, Joshua A. , Algeciras‐Schimnich, Alicia , Bornhorst, Joshua , Figdore, Daniel J. , Ashrafzadeh‐Kian, Susan , Burkett, Brian J. , Botha, Hugo , McCarter, Stuart J. , Day, Gregory S. , Graff‐Radford, Jonathan , Ramanan, Vijay K. , Jack, Clifford R. , Johnson, Sterling C. , Zetterberg, Henrik , Petersen, Ronald C.

JAMA Neurology | June 1, 2026 | Volume: 83 | Issue: 8 | Pages: 823

10.1001/jamaneurol.2026.1565 | PMID 42223932 Get It

This cross-sectional study evaluates the performance of the US Food and Drug Administration–cleared phosphorylated tau 217 (p-tau217) to β-amyloid 42 ratio cut points used to detect amyloid pathology associated with Alzheimer disease.
Current State and Needs of Clinical Laboratories in Selected Countries in Africa
Tesfazghi, Merih, Tebo, Anne E. , Harb, Roa , Okorodudu, Anthony O. , Schroeder, L, Guarner, Jeannette , Bales, Christine, Ladenson, Jack, Targowski, Allison, Cosby, Kerry, Oladipo, Olajumoke, Tesfazghi, Merih T. , Ladenson, Jack H., Oladipo, Olajumoke O.

The Journal of Applied Laboratory Medicine | May 31, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jalm/jfag089 | PMID 42335177 Get It

Abstract The Africa Working Group, under the auspices of the Global Laboratory Quality Initiative of the Association for Diagnostics & Laboratory Medicine (ADLM), conducted several educational workshops in Africa to promote laboratory quality in the region. The challenges faced in maintaining quality in clinical laboratories in low-resource countries may differ from region to region and country to country. To better understand current gaps and inform our engagement with partners in Africa, a needs assessment survey was distributed to 1427 ADLM members in Africa and further disseminated through local partners, resulting in 121 responses from participants across 8 countries in the region. Additionally, interviews were conducted with laboratory professionals from the countries surveyed. The surveys primarily focused on quality management, continuing education, budgeting, infrastructure and funding, supplies, and staffing issues. The data collected from the surveys and interviews strongly indicate that respondents face major challenges in all areas assessed, including lack of funding, lack of equipment, lack of quality control (QC) and external quality assessment (EQA) materials, gaps in quality management, lack of appropriate budgeting, staffing issues, and lack of accessible training/continuing education. Consistent with the primary focus of ADLM;s Global Quality Initiative, improved access to continuing education was identified as the primary need by the participants (58%). The assessment highlights that while a strong role for educational workshops in mitigating some of the challenges continues to exist, there is also an opportunity to broaden the scope of the working groups beyond education.
Changes in interstitial cells of Cajal calcium activity in a diabetic mouse model of delayed gastric emptying
Maalouf, Elisia, Chai, Xin-Yi , Patraw, Jack A., Cipriani, Gianluca , Linden, David R., Bernard, Cheryl E., Farrugia, Gianrico, Du, Peng , Grover, Madhusudan , Linden, David R. , Chai, Xinyi , Linden, D R , Smith-Edwards, Kristen M , Grover, Madhusudan , Farrugia, Gianrico

The Journal of Physiology | May 31, 2026 | Volume: 604 | Issue: 14 | Pages: 5800-5816

10.1113/jp290718 | PMID 42218355 Get It

Abstract Interstitial cells of Cajal (ICC) regulate gastrointestinal motility by generating electrical slow waves that orchestrate downstream calcium (Ca 2 + ) waves and coordinate smooth muscle contractions. A reduced ICC number has been reported in diabetic gastroparesis patients and in mouse models of delayed gastric emptying (DGE). However, functional changes in ICC propagating across the gastric regions in intact stomach are not well understood. The aim of this study was to develop an imaging approach to visualize ICC Ca 2+ waves in mouse stomach and determine spatiotemporal changes in mice with DGE. Tamoxifen‐treated B6.GCaMP5‐KitCreERT2 female mice were used as non‐diabetic controls (Non‐Db), while mice treated with streptozocin to induce diabetes were categorized as having normal (Db‐NGE) or delayed (Db‐DGE) gastric emptying based on emptying of solids. The ICC Ca 2+ network was imaged from excised intact mouse stomachs and subsequently opened along the lesser curvature and pinned flat. ICC Ca 2+ waves typically propagated along the greater curvature from the fundus–corpus line toward the antrum. The propagation length of ICC Ca 2+ activity was significantly decreased in Db‐DGE compared to Non‐Db and Db‐NGE and correlated to longer GE times. There was also a decrease in frequency, and the velocity was significantly faster in stomachs from Db‐DGE compared to Non‐Db and Db‐NGE. All experimental groups exhibited similar proportions of aberrant Ca 2+ propagation patterns (e.g., retrograde waves), but ectopic initiation only occurred in Db‐DGE stomachs. Thus, DGE is possibly driven by dysfunction in Ca 2+ activity in the ICC network that propagates rapidly over short distances, resulting in uncoordinated, non‐phasic muscle activity. image Key points Dysfunction of the interstitial cells of Cajal (ICC) has been implicated in diabetic gastroparesis but the changes in spatiotemporal properties of ICC network activity are not known. We developed an ex vivo Ca 2+ imaging approach to visualize ICC network activity across the entire stomach and determined changes in ICC Ca 2+ activity in a diabetic mouse model of delayed gastric emptying (GE). Decreased frequency and increased velocity of ICC Ca 2+ activity was observed in stomachs of diabetic mice with delayed GE. Ectopic initiation was a key feature associated with delayed GE. The propagation length of ICC Ca 2+ activity was inversely correlated to GE times and significantly reduced in stomach preparations from diabetic mice with delayed GE.
How We Do It: Antitragus Repair Through Single-Stage Transposition Flap
Ho, Johne, Newcomer, Jack, Carley, Sama K. , Ho, Jade Y, Newcomer, Jack

Dermatologic Surgery | May 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/dss.0000000000005198 | PMID 42201562 Get It